These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26617745)

  • 1. MicroRNA 181b promotes vascular smooth muscle cells proliferation through activation of PI3K and MAPK pathways.
    Li TJ; Chen YL; Gua CJ; Xue SJ; Ma SM; Li XD
    Int J Clin Exp Pathol; 2015; 8(9):10375-84. PubMed ID: 26617745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Choe N; Kwon JS; Kim JR; Eom GH; Kim Y; Nam KI; Ahn Y; Kee HJ; Kook H
    Atherosclerosis; 2013 Aug; 229(2):348-55. PubMed ID: 23880186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ_0002984 Promotes Cell Proliferation and Migration by Regulating miR-181b-5p/Vascular Endothelial Growth Factor Axis and PI3K-AKT Signaling Pathway in Oxidized Low-Density Lipoprotein-Treated Vascular Smooth Muscle Cells.
    Wang X; Ma C; Hou X; Zhang G; Huang Y
    J Cardiovasc Pharmacol; 2022 Apr; 79(4):501-511. PubMed ID: 34954748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation.
    Lee J; Lim S; Song BW; Cha MJ; Ham O; Lee SY; Lee C; Park JH; Bae Y; Seo HH; Seung M; Choi E; Hwang KC
    J Cell Biochem; 2015 Apr; 116(4):598-608. PubMed ID: 25389122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
    Zhang Y; Chen X
    Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.
    Kim MH; Ham O; Lee SY; Choi E; Lee CY; Park JH; Lee J; Seo HH; Seung M; Choi E; Min PK; Hwang KC
    J Cell Biochem; 2014 Oct; 115(10):1752-61. PubMed ID: 24819721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
    Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
    J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
    Huang R; Huang Y; Zeng G; Li M; Jin Y
    Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S; Gao L; Zhang D; Tian X; Kong L; Shi H; Wu L; Huang Z; Du B; Liang C; Zhang Y; Yao R
    Int J Biol Sci; 2019; 15(12):2615-2626. PubMed ID: 31754334
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway.
    Zhang W; Liu D; Han X; Ren J; Zhou P; Ding P
    Exp Cell Res; 2019 Jun; 379(2):214-224. PubMed ID: 30930138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-24 attenuates vascular remodeling in diabetic rats through PI3K/Akt signaling pathway.
    Cai W; Zhang J; Yang J; Fan Z; Liu X; Gao W; Zeng P; Xiong M; Ma C; Yang J
    Nutr Metab Cardiovasc Dis; 2019 Jun; 29(6):621-632. PubMed ID: 31005375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MiR-21 on the proliferation and migration of vascular smooth muscle cells in rats with atherosclerosis via the Akt/ERK signaling pathway.
    Sun P; Tang LN; Li GZ; Xu ZL; Xu QH; Wang M; Li L
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2216-2222. PubMed ID: 30915769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
    Li X; Du JR; Yu Y; Bai B; Zheng XY
    J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.